These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9252194

  • 1. Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
    Meijer C, de Vries EG, Dam WA, Wilkinson MH, Hollema H, Hoekstra HJ, Mulder NH.
    Br J Cancer; 1997; 76(3):290-8. PubMed ID: 9252194
    [Abstract] [Full Text] [Related]

  • 2. Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.
    Meijera C, van Luyn MJ, Nienhuis EF, Blom N, Mulder NH, de Vries EG.
    Biochem Pharmacol; 2001 Mar 01; 61(5):573-8. PubMed ID: 11239500
    [Abstract] [Full Text] [Related]

  • 3. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 4. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan 01; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 5. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
    Saris CP, van de Vaart PJ, Rietbroek RC, Blommaert FA.
    Carcinogenesis; 1996 Dec 01; 17(12):2763-9. PubMed ID: 9006117
    [Abstract] [Full Text] [Related]

  • 6. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF, Le Pla RC, Jones GD, Thomas AL, Farmer PB.
    Chem Res Toxicol; 2010 Aug 16; 23(8):1313-21. PubMed ID: 20666396
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
    Johnsson A, Olsson C, Nygren O, Nilsson M, Seiving B, Cavallin-Stahl E.
    Cancer Chemother Pharmacol; 1995 Aug 16; 37(1-2):23-31. PubMed ID: 7497593
    [Abstract] [Full Text] [Related]

  • 9. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients.
    Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Schepman AM, Shellard SA.
    Eur J Cancer; 1994 Aug 16; 30A(6):832-7. PubMed ID: 7917544
    [Abstract] [Full Text] [Related]

  • 10. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM.
    Int J Oncol; 2006 Jan 16; 28(1):237-44. PubMed ID: 16328001
    [Abstract] [Full Text] [Related]

  • 11. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM, Groenewegen G, Pluim D, Maliepaard M, Tibben MM, Huisman A, ten Bokkel Huinink WW, Schot M, Welbank H, Voest EE, Beijnen JH, Schellens JM.
    Cancer Chemother Pharmacol; 2002 Mar 16; 49(3):201-10. PubMed ID: 11935212
    [Abstract] [Full Text] [Related]

  • 12. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul 16; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 13. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
    Los G, van Vugt MJ, den Engelse L, Pinedo HM.
    Biochem Pharmacol; 1993 Oct 05; 46(7):1229-37. PubMed ID: 8216374
    [Abstract] [Full Text] [Related]

  • 14. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 05; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 15. Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.
    Welters MJ, Maliepaard M, Jacobs-Bergmans AJ, Baan RA, Schellens JH, Ma J, van der Vijgh WJ, Braakhuis BJ, Fichtinger-Schepman AM.
    Carcinogenesis; 1997 Sep 05; 18(9):1767-74. PubMed ID: 9328174
    [Abstract] [Full Text] [Related]

  • 16. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
    Chi KH, Kunugi KA, Kinsella TJ.
    Cancer Res; 1994 May 15; 54(10):2701-6. PubMed ID: 8168100
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
    Hettinga JV, Lemstra W, Meijer C, Dam WA, Uges DR, Konings AW, De Vries EG, Kampinga HH.
    Br J Cancer; 1997 May 15; 75(12):1735-43. PubMed ID: 9192975
    [Abstract] [Full Text] [Related]

  • 18. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K, Kato N, Takagi A, Koi M, Hemmi H.
    Anal Bioanal Chem; 2005 Aug 15; 382(7):1702-7. PubMed ID: 15959768
    [Abstract] [Full Text] [Related]

  • 19. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC, Fichtinger-Schepman AM, Schutte HH, van Dijk M, Lohman PH.
    Carcinogenesis; 1985 Apr 15; 6(4):561-6. PubMed ID: 4039227
    [Abstract] [Full Text] [Related]

  • 20. Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours.
    van Moorsel CJ, Pinedo HM, Smid K, Comijn EM, Voorn DA, Veerman G, Lakerveld B, Van der Vijgh WJ, Giaccone G, Postmus PE, Peters GJ.
    Eur J Cancer; 2000 Dec 15; 36(18):2420-9. PubMed ID: 11094319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.